BeiGene helped mRNA therapeutics developer Strand Therapeutics raise $52m while the Afterpay-backed AP Ventures led logistics provider Sendle's $35m series C round.
Funding
US-based mRNA therapeutics developer Strand Therapeutics secured $52m yesterday in a series A round that included biopharmaceutical company BeiGene. The corporate invested together with Redmile Group, Camford Capital, Playground Global and Anri, and Strand said the round boosted its overall funding to $66m. Playground Global had led its $6m seed round in mid-2019, participating alongside Anri and Alexandria Venture Investments, the venture capital vehicle for life science-focused real estate investment trust Alexandria Real Estate Equities.
AP Ventures, the…
